Shinji Morisaki

Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis

Yusuke Nakamura, K. Kiyotani, A. Takeuchi, 2021, AntiCancer Research.

Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy

M. Kubo, T. Morisaki, Y. Nakamura, 2022, Cancers.

C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions

Masafumi Nakamura, Y. Oda, Shu Ichimiya, 2023, Journal of Cancer.

C4orf47 Contributes to the Induction of Stem-like Properties in Gallbladder Cancer Under Hypoxia

H. Onishi, Shinji Morisaki, Shogo Masuda, 2023, AntiCancer Research.

MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia

Masafumi Nakamura, Y. Oda, Shu Ichimiya, 2023, AntiCancer Research.

Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn’s Disease

Yoshiaki Taniguchi, T. Kitazono, H. Suekane, 2023, Inflammatory Intestinal Diseases.

PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target

Masafumi Nakamura, Masayo Umebayashi, T. Morisaki, 2023, Journal of Cancer Research and Clinical Oncology.

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine

K. Kiyotani, T. Kitazono, P. Yew, 2023, Frontiers in immunology.